Post-IPO Equity - Terns Pharmaceuticals - Dec 20, 2022 Funding Round Profile - Cointime

Bitcoin $98,166.52 +0.63%
Ethereum $3,469.37 +3.40%
BNB $663.07 +1.35%
Optimism $2.26 +4.34%
Arbitrum $0.91 +7.28%
Solana $251.86 +0.75%
Polygon $0.59 +6.00%
Cosmos $8.62 -2.64%
Avalanche $45.37 +11.82%

Bitcoin $98,166.52 +0.63%
Ethereum $3,469.37 +3.40%
BNB $663.07 +1.35%
Optimism $2.26 +4.34%
Arbitrum $0.91 +7.28%
Solana $251.86 +0.75%
Polygon $0.59 +6.00%
Cosmos $8.62 -2.64%
Avalanche $45.37 +11.82%

Terns Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 86.30M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 12, 2022	Post-IPO Equity	$ 65M	Fairmount Funds Management,Venrock Healthcare Capital Partners	Detail
Oct 30, 2018	Series B	$ 80M	Decheng Capital,Lilly Asia Ventures,etc.	Detail
Jan 5, 2021	Series C	$ 87M	Deepfield,Eli Lilly,etc.	Detail
Apr 4, 2018	Series A	$ 30M	Lilly Asia Ventures	Detail
Feb 4, 2021	IPO	$ 127.50M		Detail